Implantable pulse generator for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue

• US 20070293910A1
• Filed: 07/03/2007
• Published: 12/20/2007
• Est. Priority Date: 06/10/2004
• Status: Active Grant

• Current Assignee: Medtronic Urinary Solutions, Inc. (Medtronic Plc)
• Original Assignee: NDI Medical, Inc. (Medtronic Plc)
• Inventors: Thrope, Geoffrey, Strother, Robert, Mrva, Joseph
• Granted Patent: US 8,165,692 B2
• Time in Patent Office: Days
• US Class Current: 607/48
• CPC Class Codes: A61N 1/36003 of motor muscles, e.g. for walking assistance
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/37223 Circuits for electromagnetic coupling
• CPC Class Codes: A61N 1/37276 characterised by means for reducing power consumption during telemetry
• CPC Class Codes: Y10S 128/903 Radio telemetry
• CPC Class Codes: Y10S 128/904 Telephone telemetry

Abstract

Improved assemblies, systems, and methods provide an implantable pulse generator for prosthetic or therapeutic stimulation of muscles, nerves, or central nervous system tissue, or any combination. The implantable pulse generator is sized and configured to be implanted subcutaneous a tissue region. The implantable pulse generator includes an electrically conductive case of a laser welded titanium material. Control circuitry is located within the case, the control circuitry including a rechargeable power source, a receive coil for receiving an RF magnetic field to recharge the power source, and a microcontroller for control of the implantable pulse generator. Improved assemblies, systems, and methods also provide a stimulation system for prosthetic or therapeutic stimulation of muscles, nerves, or central nervous system tissue, or any combination. The stimulation system provides at least one electrically conductive surface, a lead connected to the electrically conductive surface, and an implantable pulse generator electrically connected to the lead.

Claims

1. A neuromuscular stimulation system comprising:

at least one electrically conductive surface sized and configured for implantation in a targeted neural or muscular tissue region,

a lead electrically coupled to the electrically conductive surface, the lead sized and configured to be positioned subcutaneous a tissue surface,

an implantable pulse generator sized and configured to be coupled to the lead and positioned in subcutaneous tissue remote from the at least one electrically conductive surface,

the implantable pulse generator comprising a first non-inductive wireless telemetry circuitry using VHF/UHF signals, the first non-inductive wireless telemetry circuitry being functional at a distance as far as arm'"'"'s reach away from the patient, and being adapted for programming and interrogation of the implantable pulse generator, and

the implantable pulse generator comprising at least three power management operating modes including an active mode, an idle mode, and a dormant mode.

2. A system according to claim 1

wherein the implantable pulse generator includes a smaller end and a larger end to facilitate placement within a subcutaneous pocket small end first.

3. A system according to claim 1

wherein the implantable pulse generator includes a connection header coupled to the first wireless telemetry circuitry, the connection header being sized and configured to accept an IS-1 plug-in lead connector.

4. A system according to claim 1

further including a rechargeable power source and a power receiving coil coupled to the rechargeable power source and carried entirely within the implantable pulse generator, the power receiving coil being configured, after the pulse generator is implanted in subcutaneous tissue, to transfer received power from a transcutaneously applied radio frequency magnetic field to the rechargeable power source and recharge the power source in a time period of not more than six hours.

5. A system according to claim 4

wherein recharging of the rechargeable power source is required less than weekly.

6. A system according to claim 1

wherein the implantable pulse generator is sized and configured for implanting in subcutaneous tissue at an implant depth of between about 0.5 cm and about 1.5 cm.

7. A system according to claim 1

wherein the rechargeable power source comprises a capacity of at least 30 mA-hr.

8. A method of using the system defined in claim 1.